Medical Device Regulatory Consulting Services

Cisema delivers specialized medical device consulting services for international clients looking to access the Chinese and Asia-Pacific markets. With a deep understanding of local regulations, we help medical device manufacturers navigate the full spectrum of regulatory compliance activities. Our bilingual consulting team, located across Europe and Asia, ensures timely, accurate, and fully compliant submission of all required regulatory documents.

Our services include registration, type testing, clinical research, post-market surveillance. Whether you're a digital health startup or a blue-chip in the medical device industry, Cisema offers hands-on support and strategic guidance tailored to your product type—covering devices, combination products, and more.

We go beyond medical device regulatory affairs. As one of the few consulting firms with cross-sector capabilities, we also serve related areas within the healthcare industry such as IVDs, pharmaceuticals, biopharma, cosmetics, health foods, veterinary medicines, and consumer goods. Our integrated approach allows clients to manage compliance across multiple verticals through one trusted partner.

Medical Device Consultant - Cisema
Outsourcing service

Discover our China Medical Device Consulting Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive in China.

NMPA Legal Agent

We act as your official representative in China, handling registrations, filings, and ensuring you are fully compliant, including quality assurance and PMS requirements.

NMPA Type Testing

We provide end-to-end support for China type testing in NMPA-accredited laboratories. Our experienced test engineers offer on-site supervision to guarantee accurate and reliable results.

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research consultants will advise you, prepare the study protocol and assist setting up the clinical trial in China.

NMPA Clinical Evaluation Report

CERs can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA-compliant CERs.

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device-led.

China Medical Device Quality Compliance

We help you achieve and ensure ongoing compliance with Chinese requirements.Our experts prepare and assist you for official NMPA inspections.

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.Our specialist PMS team means you remain fully compliant at all tims.

Regulatory Outsourcing

Leverage our team of consultants and subject matter experts for specialized projects or long-term regulatory resource needs.

Medical Device Consultant

Our Hong Kong Medical Device 
Consulting Services

Our Hong Kong Medical Device Consulting Services provide targeted support to help you meet regulatory requirements and launch your products with confidence.

Hong Kong Local Responsible Person

We act as your designated Local Responsible Person (LRP), fulfilling listing and PMS obligations under MDACS.

Hong Kong IVD Registration

We support you through every stage of the Hong Kong IVD Listing process. From classification to handling regulatory requirements, we make the process as smooth as possible.

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, our team of consultants has a variety of solutions to meet your needs.

Discover Our Other Medical Device Consulting Services Across APAC

Malaysia

Singapore

Vietnam

Taiwan

Indonesia

The Philippines

Thailand

Useful Articles

View More

Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways

Learn how Malaysia classifies drug–medical device combination products and how the PMOA determines pathways and compliance responsibilities.

April 16, 2026
Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways
Laboratory professional in protective eyewear, hair cover, sterile gown, and blue nitrile gloves examining a filled syringe in a clean laboratory environment.

Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers

Understand the pathway for intraocular lens (IOL) registration in China, including NMPA requirements and key compliance steps.

April 15, 2026
Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers
A close-up of an eye with a transparent intraocular lens held by surgical tweezers positioned in front of the pupil, illustrating ophthalmic medical device use. The visual supports themes of regulatory compliance, product registration, and market access

China Hyaluronic Acid Registration: A Complete Guide

A complete guide to China hyaluronic acid registration, covering classification, NMPA requirements, and compliance steps for manufacturers.

April 16, 2026
China Hyaluronic Acid Registration: A Complete Guide
China Hyaluronic Acid Registration: A Complete Guide

Indonesia's Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know

Learn which products are covered by Indonesia's halal framework, the labeling and manufacturing obligations, and phased compliance timelines.

April 15, 2026
Indonesia's Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know
Indonesia's Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know

Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Learn how to register medical devices in Indonesia, including Authorized Representative rules, classification, dossiers, timelines, and fees.

April 15, 2026
Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers
Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Medical Devices in China: A Regulatory Glossary for NMPA Compliance

Practical China medical device glossary explaining NMPA terms, with clear comparisons to US FDA and EU MDR terminology.

April 15, 2026
Medical Devices in China: A Regulatory Glossary for NMPA Compliance
Medical Devices in China: A Regulatory Glossary for NMPA Compliance
Previous
Previous

Other Industries We Support

In addition to medical devices, we offer consulting services across regulated industries including IVDs, pharmaceuticals, biopharma, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
April 18, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

How Cisema Supported Inox Torres Group, S.L. in Successfully Renewing its China Manufacture License (SELO) for Level A2 Pressure Vessels

The China Manufacture License (CML), also known as the SELO license, is a mandatory requirement for manufacturers of pressure equipment intended for the Chinese market. Inox Torres Group, S.L.’s manufacturing site produces high-pressure vessels falling under the Level A2 scope. This license ensures compliance with China’s stringent quality and safety regulations for special equipment.

The Challenge: Managing SELO Complexity for High-Risk Equipment

Renewing a SELO license for Level A2 pressure vessels required careful coordination across regulatory, technical, and cultural dimensions.

  • Navigating Regulatory Complexity
    Navigating the complex and evolving SELO regulatory framework, particularly for high-risk products under Level A2, required meticulous planning and real-time compliance updates.
  • Ensuring Audit Readiness
    Inox Torres Group, S.L. needed to ensure all documentation and procedures were fully up to date and to select an appropriate demo product that met inspection requirements.
  • Managing Inspector Expectations
    Success depended on understanding the unspoken cultural and procedural expectations of SELO inspectors, including hosting and on-site hospitality.

Our Solution: Full-Spectrum SELO Audit Support

Recognizing the high stakes of SELO license renewal, Inox Torres Group, S.L. engaged Cisema for comprehensive regulatory and strategic support.

  • Reviewed the Quality Management System
    Cisema led the review and upgrade of the customer’s quality management system in line with the latest Chinese requirements, including a comprehensive gap analysis and revision of key documentation.
  • Audit Simulation & Preparation
    A preparatory remote audit simulation was conducted, walking through every step of the audit to ensure full readiness ahead of the on-site inspection.
  • Delivered On-Site Bilingual & Regulatory Support
    During the on-site audit, Cisema provided continuous bilingual support, interpreting inspector questions in real time and translating regulatory nuances for the customer.
  • Provided Culturally Appropriate Inspector Hosting
    Cisema arranged culturally appropriate corporate hospitality, helping establish a respectful and positive tone for the inspection. The team remained onsite throughout all audit days, including the weekend, to ensure no detail was overlooked.

The Outcome: Successful Renewal Without Disruption

Through hands-on execution and close coordination, the SELO renewal process was completed smoothly and efficiently.

  • Secured CML Renewal with Full A2 Status
    Inox Torres Group, S.L. successfully renewed its China Manufacture License for pressure vessels, maintaining its Level A2 classification.
  • Executed the Project Efficiently
    Full regulatory preparation and audit execution were completed within six months.
  • Achieved Seamless Inspector Coordination
    SELO inspectors were hosted and coordinated smoothly, with culturally aligned engagement throughout the audit.
  • Secured Regulatory Continuity  
    The renewal avoided operational disruptions and ensured compliance with updated SELO requirements.

Expertise and Efficiency: Acting as an Extension of the Client Team

Cisema’s experienced consultants acted as an extension of Inox Torres Group, S.L.’s regulatory and quality teams, providing both regulatory expertise and strategic foresight. Inspector concerns were anticipated and addressed proactively, transforming a potentially stressful process into a streamlined, well-orchestrated engagement with Chinese authorities.

Hands-on mentoring throughout the project helped the customer gain confidence and clarity in managing future SELO audits.

Why Choose Cisema

  • Strategic Regulatory Expertise: Deep understanding of Chinese bureaucracy, evolving SELO requirements, and inspector expectations.
  • Mentorship & Training: Step-by-step guidance that supported the customer’s quality team throughout the process.
  • Corporate Hospitality Excellence: Culturally aligned hosting that supports successful audit outcomes in China.
  • Audit Readiness & Precision: Gap analysis, audit simulation, and documentation refinement to pass SELO reviews efficiently.
  • End-To-End Support: Full management of the audit process, from document revision to on-site interpretation.

Further Information

Explore Cisema’s China Special Equipment (SELO) Certification services.

Learn More
China Manufacture License Renewal for Level A2 Pressure Vessels
Previous
Previous

Latest Insights

View More

Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices

Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements

April 17, 2026
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Two professionals in an office review documentation for a HealthScreen glucose monitor while examining a computer display showing a product label with model number, barcode, and QR code. One person points to the code on the screen as the other reads.

Vietnam Cuts Advertising Red Tape for Healthcare Products

Vietnam’s MoH recently published Circular drops several healthcare advertising regulations and streamlines requirements for many categories.

April 17, 2026
Vietnam Cuts Advertising Red Tape for Healthcare Products

China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software

The 26 new medical device standards cover orthopedic implants, IVDs, active devices, and software risk management.

April 17, 2026
China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software

China Mandates Full UDI Compliance for All Medical Devices by 2029

China’s NMPA mandates full UDI coverage for all medical devices by 2029, linking compliance to registration, reimbursement, and market access.

April 17, 2026
China Mandates Full UDI Compliance for All Medical Devices by 2029

China NMPA Clarifies Pre-Review for Innovative Device Clinical Trials

China’s NMPA issues new guidance on clinical trial protocol pre-review for innovative devices, impacting overseas fast-track approvals.

April 17, 2026
China NMPA Clarifies Pre-Review for Innovative Device Clinical Trials

China NMPA Releases 2025 Medical Device Registration Data Report

China NMPA’s 2025 report highlights growth in medical device approvals, including advanced imported devices.

April 17, 2026
China NMPA Releases 2025 Medical Device Registration Data Report
Previous
Previous

Get in Touch with Our Medical Device Consultants

Speak to our consultants to learn how our comprehensive services, regulatory guidance, and operational expertise can help you stay ahead in the complex medical device regulatory environment of China and Southeast Asia.

Request Proposal